This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 digital issues and online access to articles
$119.00 per year
only $9.92 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Puddu P, Puddu GM, Zaca F, Muscari A . Endothelial dysfunction in hypertension. Acta Cardiol 2000; 55: 221–232.
Lip GYH, Blann A . Von Willebrand factor: a marker of endothelial dysfunction in vascular disorders? Cardiovas Res 1997; 34: 255–265.
Blann AD, Taberner DA . A reliable marker of endothelial cell dysfunction: does it exist? Br J Haematol 1995; 90: 244–248.
Pierdomenico SD et al. Twenty-four-hour autonomic nervous function in sustained and “white coat” hypertension. Am Heart J 2000; 140: 672–677.
Blann AD . Von Willebrand factor and the endothelium in vascular disease. Br J Biomed Sci 1993; 50: 125–134.
Blann AD, McCollum CN . Von Willebrand factor, endothelial cell damage and atherosclerosis. Eur J Vasc Surg 1994; 8: 10–15.
Blann AD, Naqvi T, Waite M, McCollum CN . Von Willebrand factor and endothelial damage in essential hypertension. J Hum Hypertens 1993; 7: 107–111.
Kario K et al. Factor VII hyperactivity and endothelial cell damage are found in elderly hypertensives only when concomitant with microalbuminuria. Arterioscler Thromb Vasc Biol 1996; 16: 455–461.
Chrysant SG . Treatment of white coat hypertension. Curr Hypertens Rep 2000; 2: 412–417.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Çoban, E., Timuraǧaoǧlu, A. & Özdoǧan, M. Endothelial dysfunction in patients with white coat hypertension. J Hum Hypertens 18, 71–72 (2004). https://doi.org/10.1038/sj.jhh.1001629
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.jhh.1001629
This article is cited by
-
The GG genotype of the −152 G/A vascular endothelial growth factor (VEGF) polymorphism predisposes to hypertension-related chronic kidney disease
Molecular Biology Reports (2016)
-
The GA genotype of the −1154 G/A (rs1570360) vascular endothelial growth factor (VEGF) is protective against hypertension-related chronic kidney disease incidence
Molecular and Cellular Biochemistry (2016)
-
Insights into human hypertension: the role of endothelial dysfunction
Journal of Human Hypertension (2006)